PINK Stock Overview
Perimeter Medical Imaging AI, Inc., a medical technology company, develops and commercializes advanced imaging tools that allow surgeons, radiologists, and pathologists to visualize microscopic tissue structures during a clinical procedure.
Perimeter Medical Imaging AI Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||CA$1.64|
|52 Week High||CA$5.20|
|52 Week Low||CA$1.49|
|1 Month Change||-13.68%|
|3 Month Change||-0.61%|
|1 Year Change||-32.23%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-4.09%|
Recent News & Updates
Here's Why We're Not Too Worried About Perimeter Medical Imaging AI's (CVE:PINK) Cash Burn Situation
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
|PINK||CA Medical Equipment||CA Market|
Return vs Industry: PINK exceeded the Canadian Medical Equipment industry which returned -45.2% over the past year.
Return vs Market: PINK underperformed the Canadian Market which returned -7.3% over the past year.
|PINK Average Weekly Movement||10.4%|
|Medical Equipment Industry Average Movement||10.3%|
|Market Average Movement||9.9%|
|10% most volatile stocks in CA Market||18.3%|
|10% least volatile stocks in CA Market||3.8%|
Stable Share Price: PINK is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: PINK's weekly volatility (10%) has been stable over the past year.
About the Company
Perimeter Medical Imaging AI, Inc., a medical technology company, develops and commercializes advanced imaging tools that allow surgeons, radiologists, and pathologists to visualize microscopic tissue structures during a clinical procedure. The company offers an optical coherence tomography (OCT) imaging system provides clinicians with cross-sectional of tissues down to 2 mm dept. This OCT imaging system consists of S-series OCT, B-series OCT, and OCT imaging console.
Perimeter Medical Imaging AI Fundamentals Summary
|PINK fundamental statistics|
Is PINK overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|PINK income statement (TTM)|
|Cost of Revenue||CA$9.08k|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.25|
|Net Profit Margin||-13,382.54%|
How did PINK perform over the long term?See historical performance and comparison
Is PINK undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 3/6
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PINK?
Other financial metrics that can be useful for relative valuation.
|What is PINK's n/a Ratio?|
Price to Book Ratio vs Peers
How does PINK's PB Ratio compare to its peers?
|PINK PB Ratio vs Peers|
|Company||PB||Estimated Growth||Market Cap|
PRN Profound Medical
NSCI Nanalysis Scientific
TMD Titan Medical
TLT Theralase Technologies
PINK Perimeter Medical Imaging AI
Price-To-Book vs Peers: PINK is good value based on its Price-To-Book Ratio (2.6x) compared to the peer average (7.1x).
Price to Earnings Ratio vs Industry
How does PINK's PE Ratio compare vs other companies in the CA Medical Equipment Industry?
Price-To-Book vs Industry: PINK is expensive based on its Price-To-Book Ratio (2.6x) compared to the North American Medical Equipment industry average (2.5x)
Price to Book Ratio vs Fair Ratio
What is PINK's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PB Ratio||2.6x|
|Fair PB Ratio||n/a|
Price-To-Book vs Fair Ratio: Insufficient data to calculate PINK's Price-To-Book Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of PINK when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: PINK (CA$1.64) is trading below our estimate of fair value (CA$13.23)
Significantly Below Fair Value: PINK is trading below fair value by more than 20%.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.
Discover undervalued companies
How is Perimeter Medical Imaging AI forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
Future Growth Score2/6
Future Growth Score 2/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PINK is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: PINK is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: PINK is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: PINK's revenue (66.8% per year) is forecast to grow faster than the Canadian market (5.8% per year).
High Growth Revenue: PINK's revenue (66.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PINK's Return on Equity is forecast to be high in 3 years time
Discover growth companies
How has Perimeter Medical Imaging AI performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: PINK is currently unprofitable.
Growing Profit Margin: PINK is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: PINK is unprofitable, and losses have increased over the past 5 years at a rate of 26.5% per year.
Accelerating Growth: Unable to compare PINK's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: PINK is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-0.2%).
Return on Equity
High ROE: PINK has a negative Return on Equity (-39.63%), as it is currently unprofitable.
Discover strong past performing companies
How is Perimeter Medical Imaging AI's financial position?
Financial Health Score4/6
Financial Health Score 4/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: PINK's short term assets (CA$49.7M) exceed its short term liabilities (CA$2.3M).
Long Term Liabilities: PINK's short term assets (CA$49.7M) exceed its long term liabilities (CA$9.7M).
Debt to Equity History and Analysis
Debt Level: PINK has more cash than its total debt.
Reducing Debt: Insufficient data to determine if PINK's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: PINK has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if PINK has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
Discover healthy companies
What is Perimeter Medical Imaging AI current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Cash Flow Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate PINK's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate PINK's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if PINK's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if PINK's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as PINK has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Jeremy Sobotta serves as President at Perimeter Medical Imaging AI, Inc. and serves as its Chief Executive Officer since October 20, 2020. Mr. Sobotta served as Chief Financial Officer of Perimeter Med...
CEO Compensation Analysis
|Jeremy Sobotta's Compensation vs Perimeter Medical Imaging AI Earnings|
|Date||Total Comp.||Salary||Company Earnings|
|Jun 30 2022||n/a||n/a|
|Mar 31 2022||n/a||n/a|
|Dec 31 2021||n/a||n/a|
|Sep 30 2021||n/a||n/a|
|Jun 30 2021||n/a||n/a|
|Mar 31 2021||n/a||n/a|
|Dec 31 2020||CA$369k||CA$318k|
|Sep 30 2020||n/a||n/a|
|Jun 30 2020||n/a||n/a|
|Mar 31 2020||n/a||n/a|
|Dec 31 2019||CA$30k||CA$27k|
Compensation vs Market: Insufficient data to establish whether Jeremy's total compensation is reasonable compared to companies of similar size in the Canadian market.
Compensation vs Earnings: Jeremy's compensation has increased whilst the company is unprofitable.
Experienced Management: PINK's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
Experienced Board: PINK's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
|26 Jan 22||BuyCA$252,000||Aaron Davidson||Individual||84,000||CA$3.00|
|26 Jan 22||BuyCA$15,000||Merle Boon||Individual||5,000||CA$3.00|
|26 Jan 22||BuyCA$126,000||Suzanne Foster||Individual||42,000||CA$3.00|
|26 Jan 22||BuyCA$30,000||Jeremy Sobotta||Individual||10,000||CA$3.00|
|26 Jan 22||BuyCA$90,000||Ian Mortimer||Individual||30,000||CA$3.00|
|30 Sep 21||BuyCA$340||Merle Boon||Individual||150||CA$2.27|
|29 Sep 21||BuyCA$19,182||Jeremy Sobotta||Individual||10,100||CA$1.94|
|Owner Type||Number of Shares||Ownership Percentage|
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 42.7%.
|Ownership||Name||Shares||Current Value||Change %||Portfolio %|
Perimeter Medical Imaging AI, Inc.'s employee growth, exchange listings and data sources
- Name: Perimeter Medical Imaging AI, Inc.
- Ticker: PINK
- Exchange: TSXV
- Founded: 2013
- Industry: Health Care Equipment
- Sector: Healthcare
- Implied Market Cap: CA$104.975m
- Shares outstanding: 64.01m
- Website: https://www.perimetermed.com
Number of Employees
- Perimeter Medical Imaging AI, Inc.
- 359 Eastern Avenue
- Suite 110
- M4M 1B7
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|PINK||TSXV (TSX Venture Exchange)||Yes||Common Shares||CA||CAD||Jul 2020|
|4PC||DB (Deutsche Boerse AG)||Yes||Common Shares||DE||EUR||Jul 2020|
|PYNK.F||OTCPK (Pink Sheets LLC)||Yes||Common Shares||US||USD||Jul 2020|
|4PC||BST (Boerse-Stuttgart)||Yes||Common Shares||DE||EUR||Jul 2020|
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/09/26 00:00|
|End of Day Share Price||2022/09/26 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.